NIP
COLL icon

Nicholas Investment Partners’s Collegium Pharmaceutical COLL Stock Holding History

Nicholas Investment Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-209,447
Closed -$5M – 221
2018
Q2 		$5M Buy
209,447
+19,012
+10% +$467K 0.35% 84
2018
Q1 		$4.87M Sell
190,435
-5,658
-3% -$135K 0.35% 88
2017
Q4 		$3.62M Buy
+196,093
New +$2.81M 0.24% 141
2016
Q2 		– Sell
-46,773
Closed -$849K – 300
2016
Q1 		$849K Buy
+46,773
New +$850K 0.06% 287

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nicholas Investment Partners's COLL Position: Q3 2018 in Review

Nicholas Investment Partners sold out of Collegium Pharmaceutical (COLL) in Q3 2018, closing a stake of 209,447 shares — an estimated $5M sold.

Nicholas Investment Partners first reported a position in COLL in Q1 2016 and held it in 4 quarters. The position peaked at $5M in Q2 2018. 124 funds tracked by Wall St. Rank hold COLL as of Q3 2018.

  • Nicholas Investment Partners reported no remaining Collegium Pharmaceutical position as of Q3 2018 after selling out during the quarter.
  • Nicholas Investment Partners sold 209,447 Collegium Pharmaceutical shares in Q3 2018, an estimated $5M.
  • Nicholas Investment Partners first reported a position in Collegium Pharmaceutical in Q1 2016 and held it in 4 quarters.
  • Nicholas Investment Partners's Collegium Pharmaceutical position peaked at $5M in Q2 2018.
  • 124 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2018.

Based on Nicholas Investment Partners's 13F filing for Q3 2018, filed 14 Nov 2018.